c.delgado
TL2 Moderator · Genoa
Contributes reviews on supplier material. Based in Genoa.
Joined 4 October 2024 · last posted 3d
76Posts here
1Topics
0Solutions
190Likes received
136Likes given
18Badges
98Days visited
1.1kPosts read
Recent activity
Full stream-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #26 · Compounds › Oral incretins · 25 Jul 2026 · 26 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Common supplements people ask about, assessed one at a time Replied, post #92 · Practice › Interactions · 24 Jul 2026 · 3 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #24 · Analytics › Mass spectrometry · 24 Jul 2026 · 8 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #97 · Evidence › Journal club · 21 Jul 2026 · 12 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Seven-day rolling means and why weekly readings mislead Replied, post #74 · Outcomes › Progress reports · 21 Jul 2026 · 32 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #61 · Analytics › Home & field testing · 7 Jul 2026 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #27 · Compounds › Semaglutide · 4 Jul 2026 · 0 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Reading a syringe in poor light, and how to avoid needing to — what changed since Replied, post #8 · Devices › Syringes & needles · 1 Jul 2026 · 7 likes I read post #6 twice before replying, because I had assumed the opposite. Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the…
-
Prescription requirements and telehealth models — a second dataset Replied, post #80 · Sourcing › Regulatory · 26 Jun 2026 · 0 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Publication patterns in the BPC-157 literature, examined Replied, post #9 · Compounds › Repair & healing peptides · 7 Jun 2026 · 6 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #91 · Sourcing › Logistics · 4 Jun 2026 · 3 likes post #90 is right about the mechanism and I think understates the practical bit. Customs holds: if a parcel is held at customs and you can contact customs directly,…
-
The best-written scientific paper you have read Replied, post #69 · Lounge › Off topic · 28 May 2026 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.